摆脱认知障碍:运动诱导分子的魔力
Wenbo Liu1, Hui Zhang1, Qiuting Zeng1
1Department of Anesthesiology & Key Laboratory of Clinical Science and Research, Department of Anesthesiology, Zhongda, Hospital, Medical School, Southeast University, China.
Brain, behavior, & immunity - health
|October 23, 2025
概括
运动分子通过各种途径增强大脑功能,促进抗衰老和神经退行性疾病的认知衰退的弹性. 针对这些运动模拟分子提供了针对认知障碍的非药物治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 运动生理学 运动生理学
- 分子生物学分子生物学
背景情况:
- 运动对大脑健康和认知功能产生积极影响.
- 肌肉与大脑之间的沟通对于保持认知性至关重要,特别是在衰老和神经退行性疾病期间.
- 运动期间释放的特定分子在调解这些效应方面发挥着关键作用.
研究的目的:
- 阐明运动诱导的认知益处背后的分子机制.
- 探索肌肉-大脑交叉声在认知弹性中的作用.
- 根据炼模拟来确定基于认知障碍的潜在治疗标.
主要方法:
- 分析运动诱导的分子及其对神经通路的影响.
- 调查肌肉和大脑之间的营养,免疫和代谢信号.
- 检查诸如甲素B (CTSB) 和乳酸等分子的取决于环境的作用.
主要成果:
- 运动诱导的分子通过热量,免疫和代谢途径调节认知.
- 肌肉与大脑的交叉语音显著促进了在衰老和神经退行过程中的认知性.
- 像CTSB和乳酸盐这样的分子表现出双重作用,根据特定的生物背景,它们具有保护性或病理性作用.
结论:
- 运动介导的分子信号是维持认知健康的关键因素.
- 向运动模仿分子是管理认知障碍的有希望的非药物战略.
- 了解这些分子的双重作用对于开发有效的治疗干预措施至关重要.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552
01:23Role of Neurotransmitters in Memory
2.5K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.5K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K